Literature DB >> 7961863

Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.

A Sahu1, M K Pangburn.   

Abstract

C3 (native complement component 3) plays a central role in the activation of complement and in the transport and processing of immune complexes. Proteolytic activation of C3 exposes a highly reactive thioester bond which preferentially reacts with the hydroxyl groups of acceptor molecules on activators such as immune complexes or carbohydrates on microorganisms. Recently, a C3 attachment site has been localized on the CH1 domain of IgG1 between Val134 and Lys156. We have synthesized a series of peptide analogs of this region to identify the preferred residue for C3b (the proteolytically activated form of C3) attachment. The parent peptide included all 6 hydroxyl-containing amino acids present in the proposed binding site and was highly reactive with activated C3. The C3b-peptide complex was sensitive to hydroxylamine as was C3b-IgG indicating that both were ester-linked. The kinetic profile of hydrolysis of the C3b-peptide complex under physiologic conditions was found to be nearly identical to the profiles of C3b-IgG, C3b-IgG1, and C3b-glycerol complexes. Site-specific amino acid substitution of threonine and serine residues in the peptide indicated that, in contrast to the attachment site in C4b, little or no attachment occurred at serine residues. The threonine corresponding to Thr144 in the CH1 domain of IgG was found to be the major acceptor site for C3b. Thr148 was the second most reactive site on the peptide, but this residue is buried in native IgG.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961863

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.

Authors:  E Jelezarova; A Vogt; H U Lutz
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 3.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

4.  Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.

Authors:  Rajashri Shende; Sarah Sze Wah Wong; Srikanth Rapole; Rémi Beau; Oumaima Ibrahim-Granet; Michel Monod; Karl-Heinz Gührs; Jayanta Kumar Pal; Jean-Paul Latgé; Taruna Madan; Vishukumar Aimanianda; Arvind Sahu
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

5.  A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b.

Authors:  Hua Zhou; Henrik Olsen; Edward So; Emmanuel Mérigeon; Denis Rybin; Jane Owens; Gregory LaRosa; David S Block; Scott E Strome; Xiaoyu Zhang
Journal:  Blood Adv       Date:  2017-03-14

6.  Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria.

Authors:  Saswati Panda; Jing Zhang; Nguan Soon Tan; Bow Ho; Jeak Ling Ding
Journal:  EMBO J       Date:  2013-09-03       Impact factor: 11.598

7.  Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4.

Authors:  Daniela Bumbaca; Anne Wong; Elizabeth Drake; Arthur E Reyes; Benjamin C Lin; Jean-Philippe Stephan; Luc Desnoyers; Ben-Quan Shen; Mark S Dennis
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

8.  Detection of complement activation using monoclonal antibodies against C3d.

Authors:  Joshua M Thurman; Liudmila Kulik; Heather Orth; Maria Wong; Brandon Renner; Siranush A Sargsyan; Lynne M Mitchell; Dennis E Hourcade; Jonathan P Hannan; James M Kovacs; Beth Coughlin; Alex S Woodell; Matthew C Pickering; Bärbel Rohrer; V Michael Holers
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

Review 9.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

Review 10.  Discrimination between host and pathogens by the complement system.

Authors:  Michael K Pangburn; Viviana P Ferreira; Claudio Cortes
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.